PRODUCT LITERATURE
Glycyrrhizin-Induced Reduction of ALT in European Patients WIth Chronic Hepatitis C
In Japan, ALT normalization induced by long-term i.v. glycyrrhizin treatment reportedly reduces the progression of liver disease to hepatocellular carcinoma in chronic hepatitis C patients. The aim of this study was to evaluate the short-term (4-wk) feasibility and efficacy on serum ALT of three or six times per week i.v glycyrrhizin therapy in European patients
No other version available